CompletedNCT02918097
Treatment Choices and Quality of Life During Depressive Episodes in Bipolarity
About this title
Read the official source — NCT02918097Medication studyAges 18–65
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMay 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 78
- Sponsor
- Federal University of Rio Grande do Sul
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02918097
- Official title
Show the full official title
Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Federal University of Rio Grande do Sul, a university.
Did this study involve medication?
Yes. The study involved medication, including Lithium Carbonate, Sertraline, Nortriptyline and Risperidone.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
